Health Care/Hospital
Lunit Backs the Potential of Tertiary Lymphoid Structures Analysis as an Emerging Biomarker for Lung Cancer Treatment - to be presented at WCLC 2023
- A collaborative study demonstrates that AI analysis of Tertiary Lymphoid Structures (TLS) in tumors can predict treatment response in non-small cell lung cancer patients SEOUL, South Korea, Aug. 21, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for canc...
2023-08-21 21:00
1923
CanariaBio Achieves Significant Milestone with FDA's Orphan Drug Designation for MAb-AR20.5 Targeting Pancreatic Cancer
The investigational monoclonal antibody becomes the first to target Mucin 1 (MUC1) and receive this designation. PYEONGTAEK, South Korea, Aug. 21, 2023 /PRNewswire/ -- CanariaBio Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative immun...
2023-08-21 20:00
1660
YGF Inc. Launches New Product Developed With 'Fire Evacuation Mask' Patent Technology
* Selected as a pilot purchase product for technology development by the Ministry of SMEs and Startups in 2023 SEOUL, South Korea, Aug. 21, 2023 /PRNewswire/ -- When fire or explosion breaks out in collective buildings or high-rise buildings, especially hospitals, and nursing facilities, which ...
2023-08-21 20:00
1177
Zepp Health Corporation Reports Second Quarter 2023 Unaudited Financial Results
AMSTERDAM, Aug. 21, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today reported revenues ofRMB0.65 billion (US$89.4 million); a basic and diluted net loss per share of RMB0.29 (US$0.04); and a basic and diluted net loss per ADS ofRMB1.15 (US$0.16) for the se...
2023-08-21 18:15
2246
Hummingbird Bioscience to Present Poster on HMBD-001 Combination Strategy for Squamous Non-Small Cell Lung Cancer at World Conference on Lung Cancer 2023
HOUSTON and SINGAPORE, Aug. 21, 2023 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced an upcoming poster presentation at the IASLC 2023 World Conference ...
2023-08-21 17:58
1359
So-Young Reports Unaudited Second Quarter 2023 Financial Results
BEIJING, Aug. 21, 2023 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial resul...
2023-08-21 17:30
2700
magAssist's NyokAssist™️ granted Designation by the FDA as a Breakthrough Device
SUZHOU, China, Aug. 21, 2023 /PRNewswire/ -- Recently, magAssist's NyokAssist™ Interventional Ventricular Assist Device (hereinafter referred to as NyokAssist™), has been granted designation as a breakthrough device by the U.S. Food and Drug Administration (FDA) in Breakthrough Device Program. Th...
2023-08-21 14:34
2004
Everest Medicines Announces Partner Calliditas Therapeutics Receives FDA Priority Review for Full Approval of Nefecon® for the Treatment of IgA Nephropathy
SHANGHAI, Aug. 21, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company") announced today that U.S. Food and Drug Administration (FDA) has accepted the submission for the supplemental New Drug Application (sNDA) for Nefecon® from its partner Calliditas Therapeutics AB ...
2023-08-21 08:20
1800
Sisram Medical to Report H1 2023 Financial Results on August 23 and Hold a Conference Call on August 24
H1 2023 conference call to be held on August 24, at 8:00 a.m. Eastern Time HONG KONG, Aug. 20, 2023 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred as the " Group"), a global consumer wellness group featuring a first-of-it...
2023-08-20 10:14
3706
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination
NEW YORK, Aug. 18, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ: UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination fromAugust 19, 2023 to September 19, 2023, for each public share that...
2023-08-19 04:30
5077
Boryung Partners with AIAA to Host 'Humans In Space Symposium' at 2023 ASCEND
* Boryung to host HIS Symposium at 2023 ASCEND in Las Vegas this October * Over 2,000 global space experts are set to attend ASCEND, the world's premier collaborative, outcomes-driven, interdisciplinary event designed to accelerate the building of our sustainable off-world future * Boryung w...
2023-08-19 01:00
2343
3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling
REYKJAVIK, Iceland and BERLIN, Aug. 18, 2023 /PRNewswire/ -- Reykjavik-based drug discovery company, 3Z, andGermany/US-based causal AI firm, biotx.ai, have joined forces in a strategic partnership aimed at revolutionizing ADHD drug development. By leveraging advanced AI modelling techniques, the ...
2023-08-18 22:45
2682
World Leading Rehabilitation Expert Prof. Dr. Christopher Gutenbrunner Visits Siyi Intelligence
SHANGHAI, Aug. 18, 2023 /PRNewswire/ -- On August 15th, Prof. Dr. Christopher Gutenbrunner, the former chief physician and Head of Department at the Clinic for Rehabilitation Medicine at Hannover Medical School, Rehabilitation international President-elect, Past-president of the Global Rehabilita...
2023-08-18 21:00
2398
VIGILL Triumphs as "Excellence in Women's Intimate Hygiene Products Brand" at The LICTA 2022 Awards
KUALA LUMPUR, Malaysia, Aug. 18, 2023 /PRNewswire/ -- VIGILL, Taiwan's leading women's intimate care brand, proudly announces its recognition as the "Excellence in Women's Intimate Hygiene Products Brand" at the 5th Lang International Corporate Titan Awards (LICTA 2022) inMalaysia. VIGILL stands ...
2023-08-18 19:15
4893
Inmagene's anti-OX40 mAb demonstrated an extended half-life and a favorable safety profile in a Phase I study
* IMG-007 has the potential to provide Q12W or less frequent dosing based on an extended half-life * IMG-007 has demonstrated a favorable safety profile, consistent with a silenced ADCC function via bioengineering * IMG-007 is being evaluated in two global proof-of-concept trials SAN DIEGO,...
2023-08-18 19:00
4560
Nature-inspired pressure sensing technology aims to transform healthcare and surgical robots
NUS researchers take a leaf out of nature's book to develop 'eAir' — an
aero-elastic sensor that revolutionises the way pressure is detected
SINGAPORE, Aug. 18, 2023 /PRNewswire/ -- Researchers at the National
University of Singapore
2023-08-18 17:54
1594
United Imaging Healthcare delivers its 2023 Half-Year report, with revenue growth of 26.35% in the first half of 2023
SHANGHAI, Aug. 18, 2023 /PRNewswire/ -- United Imaging Healthcare (SSE:688271), a global innovator in cutting-edge medical imaging and radiotherapy equipment, has unveiled its highly anticipated 2023 half-year report, revealing robust growth. The report indicates that the company achieved5.27 bil...
2023-08-18 17:29
2459
JinMed (NASDAQ: ZJYL) Rings the Nasdaq Stock Market Closing Bell on August 17
CHANGZHOU, China, Aug. 17, 2023 /PRNewswire/ -- Jin Medical International Limited ("the Company" or "JinMed") (NASDAQ: ZJYL), the world's leading provider of rehabilitation equipment, rang the bell at the New York Stock Exchange by its Chairman and CEOWang Erqi on August 17, to celebrate the Com...
2023-08-18 11:36
4044
QiLu Pharmaceutical's Iruplinalkib Phase III INSPIRE Study Researched Primary Endpoint and was Selected for 2023 WCLC Oral Presentation
JINAN, China, Aug. 18, 2023 /PRNewswire/ -- August 16, 2023, at the 2023 World Conference on Lung Cancer (WCLC), the complete list of selected abstracts was announced, among which QiLu Pharmaceutical's iruplinalkib phase III clinical trial (INSPIRE) results were chosen for oral presentation at th...
2023-08-18 09:50
2299
Thrombotic AEs of Hemlibra (emicizumab) were 2.8 times more frequent than those of FVIII replacements.
* Analyzed the FDA FAERS data…to compare the thrombotic AEs of Hemlibra vs. FVIII replacements. YONGIN, South Korea, Aug. 17, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a South Korean biopharmaceutical company, announced on August 17, 2023 that it has presented the results of analyzing and...
2023-08-18 08:58
2098
Week's Top Stories
Most Reposted
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
[Picked up by 350 media titles]
2024-06-19 11:00
Tan Xuguang: Enter South Korea, Full Focus on Business in the "Doorstep" Market
[Picked up by 335 media titles]
2024-06-16 19:38
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
[Picked up by 331 media titles]
2024-06-20 16:24
MoneyGram Announces Partnership with Rashid Khan to Promote the Company's Trusted and Reliable Services in Afghanistan and Around the World
[Picked up by 327 media titles]
2024-06-18 09:00
Tan Xuguang: Southeast Asia Product Exports Must Navigate with a "Battle Plan" and Transform
[Picked up by 322 media titles]
2024-06-18 15:45
Most Read
Tan Xuguang: Enter South Korea, Full Focus on Business in the "Doorstep" Market
2024-06-16 19:38
11738
Tan Xuguang: Southeast Asia Product Exports Must Navigate with a "Battle Plan" and Transform
2024-06-18 15:45
10986
MoneyGram Announces Partnership with Rashid Khan to Promote the Company's Trusted and Reliable Services in Afghanistan and Around the World
2024-06-18 09:00
10191
